Navigation Links
Venugopal Should Not Have Gone Public: Ramadoss

Union Health Minister Anbumani Ramadoss came down heavily on AIIMS Director P Venugopal for accusing him of 'interfering' in the functioning of the premier institute // and threatening to resign, saying he should not have gone public on the issue.

Speaking to PTI, Ramadoss said, 'It is very wrong that he has gone public. If he had any problem, he could have discussed with me. I was and am always available.' Denying that he had interfered in the functioning of AIIMS, he said as president of the institute, he had certain obligations and duties to perform.

'Is performing duty interference?' he asked adding that the charges levelled against him by Venugopal were 'rubbish'.

Justifying the appointment of a dean for AIIMS, he said the post had remained vacant for a long time. 'How could a prestigious institute function without a dean for a long time?' he asked.

Ramadoss said the fund allocation for AIIMS had been hiked from Rs 350 crore to Rs 500 crore during his tenure. He has also made the trauma care centre at the institute functional, besides completing the construction of a building for cancer care.

'If all this is interference, I am glad to interfere,' he said.

Ramadoss said when he had become the Health Minister, the lack of administration in AIIMS was visible. He had taken steps to tone up the administration. The charges against him were a 'continuation' of the anti-quota stir of last month, he said.

(Source:PTI News)
'"/>




Page: 1

Related medicine news :

1. AIIMS Doctors Seeks Ramadoss Intervention For Venugopal’s Remova
2. AIIMS Director Venugopal Sacked
3. Venugopal will not be Sacked Before Court Verdict: Central Government
4. Delhi High Court Stays Venugopals Removal
5. Normalcy Returns To AIIMS; Venugopal Attends Office
6. AIIMS Official Files Complaint Against Venugopal
7. AIIMS Director Venugopal Removed from Additional Post
8. Court Issues Notice to Venugopal Over Fund Irregularities
9. Babies Should Get Vitamin D Supplement
10. How Much Should Athletes Drink?
11. Angioplasty Should be the Standard
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/25/2017)... CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music video ... above footage and sound in the timeline and write in the lyrics to any song. ... flying back out. Each line of the text can be added modularly for optimal control. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... With a heatwave currently bearing down on Northern ... out at the pool. Being swimsuit ready is easy with laser hair removal. , ... again can be a burdensome routine when all you want to do is get out, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. ... 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine ... visits to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation ... significant harm to people with all chronic conditions, including mental illnesses, while increasing ... place the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: